<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04016363</url>
  </required_header>
  <id_info>
    <org_study_id>19-TEMP815870-BO</org_study_id>
    <nct_id>NCT04016363</nct_id>
  </id_info>
  <brief_title>Impact of the ProbeFix on the Workflow of Pharmacological Stress Echocardiography Examinations</brief_title>
  <official_title>Impact of the ProbeFix on the Workflow of Pharmacological Stress Echocardiography Examinations: a Prospective, Randomized Controlled Open Label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amir Abbas Mahabadi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pharmacological stress-echocardiography examinations are routinely performed in daily
      clinical practice. Usually, the echo probe is manually placed on the patient's thorax by the
      physician. The ProbeFix is a novel device, enabling the fixation of the ultrasound probe on
      the patient's thorax. Therefore, there is no need to manually hold the probe. This may
      improve the standardization of the examination and my reduce its duration. The present trial
      will investigate, whether the utilization of the ProbeFix reduces the duration of
      stress-echocardiography examinations and improves standardization of image acquisition.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of stress-echocardiography examination</measure>
    <time_frame>During the examination</time_frame>
    <description>Duration from start of dobutamine infusion to end of stage IV of dobutamine infusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiography axis deviation in 4 chamber view</measure>
    <time_frame>During the examination</time_frame>
    <description>In 3-dimensional 4-chamber view, the deviation of the axis as compared to baseline will be assessed</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>During the examination</time_frame>
    <description>Assessment of cost-effectiveness, comparing a potential benefit in exam duration with costs of the ProbeFix</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>ProbeFix arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The echocardiography probe is fixated on the patient's thorax using the ProbeFix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controll arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The sonographer manually holds the probe on the patient's thorax</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ProbeFix</intervention_name>
    <description>ProbeFix vs. manual hold of the ultrasound probe during pharmacological stress-echocardiography examinations</description>
    <arm_group_label>ProbeFix arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual hold</intervention_name>
    <description>ProbeFix vs. manual hold of the ultrasound probe during pharmacological stress-echocardiography examinations</description>
    <arm_group_label>Controll arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing clinically indicated pharmacological stress-echocardiography

          -  Willingness to participate

        Exclusion Criteria:

          -  Pharmacological stress echocardiography indication other than evaluation of stress
             induced ischemia (e.g. Low-Flow-Low-Gradient aortic valve stenoseis)

          -  poor image quality

          -  Early termination of the stress-echocardiography examination for clinical reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Amir A Mahabadi, MD</last_name>
      <phone>+4920172384822</phone>
      <email>amir-abbas.mahabadi@uk-essen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 8, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2019</study_first_posted>
  <last_update_submitted>September 25, 2019</last_update_submitted>
  <last_update_submitted_qc>September 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Amir Abbas Mahabadi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

